Correlation Between Scpharmaceuticals and Sonnet Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and Sonnet Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and Sonnet Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and Sonnet Biotherapeutics Holdings, you can compare the effects of market volatilities on Scpharmaceuticals and Sonnet Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of Sonnet Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and Sonnet Biotherapeutics.
Diversification Opportunities for Scpharmaceuticals and Sonnet Biotherapeutics
0.87 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Scpharmaceuticals and Sonnet is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and Sonnet Biotherapeutics Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sonnet Biotherapeutics and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with Sonnet Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sonnet Biotherapeutics has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and Sonnet Biotherapeutics go up and down completely randomly.
Pair Corralation between Scpharmaceuticals and Sonnet Biotherapeutics
Given the investment horizon of 90 days Scpharmaceuticals is expected to generate 0.6 times more return on investment than Sonnet Biotherapeutics. However, Scpharmaceuticals is 1.67 times less risky than Sonnet Biotherapeutics. It trades about -0.01 of its potential returns per unit of risk. Sonnet Biotherapeutics Holdings is currently generating about -0.09 per unit of risk. If you would invest 652.00 in Scpharmaceuticals on August 30, 2024 and sell it today you would lose (278.00) from holding Scpharmaceuticals or give up 42.64% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Scpharmaceuticals vs. Sonnet Biotherapeutics Holding
Performance |
Timeline |
Scpharmaceuticals |
Sonnet Biotherapeutics |
Scpharmaceuticals and Sonnet Biotherapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Scpharmaceuticals and Sonnet Biotherapeutics
The main advantage of trading using opposite Scpharmaceuticals and Sonnet Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, Sonnet Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sonnet Biotherapeutics will offset losses from the drop in Sonnet Biotherapeutics' long position.Scpharmaceuticals vs. Milestone Pharmaceuticals | Scpharmaceuticals vs. Oncolytics Biotech | Scpharmaceuticals vs. Seres Therapeutics | Scpharmaceuticals vs. DiaMedica Therapeutics |
Sonnet Biotherapeutics vs. Bright Minds Biosciences | Sonnet Biotherapeutics vs. HP Inc | Sonnet Biotherapeutics vs. Intel | Sonnet Biotherapeutics vs. Chevron Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Stocks Directory Find actively traded stocks across global markets | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |